CONDENSED CONSOLIDATED STOCKHOLDERS' EQUITY STATEMENTS (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Convertible Preferred Stock [Member]	Total	Cumulative Effect, Period of Adoption, Adjustment [Member] Accumulated Deficit [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]
Balance at Dec. 31, 2018	$ 6,662,351	$ 7,348,390	$ (25,734,088)	$ 20,150,116	$ 8,426,769
Balance (ASU 2016-02 [Member]) at Dec. 31, 2018						$ (103,015)	$ (103,015)
Balance (in shares) at Dec. 31, 2018	66,623,514,522			20,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with cashless exercise of Series A warrants	$ 7,498	(4,386)			3,112
Issuance of common stock in connection with cashless exercise of Series A warrants (in shares)	74,979,719
Issuance of awarded stock for board members	$ 100,000	(100,000)			0
Issuance of awarded stock for board members (in shares)	1,000,000,000
Stock-based compensation expense			343,824		343,824
Net loss			(3,167,146)		(3,167,146)
Balance at Sep. 30, 2019	$ 6,769,849	7,587,828	(29,004,249)	$ 20,150,116	5,503,544
Balance (in shares) at Sep. 30, 2019	67,698,494,241			20,150
Balance at Jun. 30, 2019	$ 6,664,526	7,543,370	(27,853,946)	$ 20,150,116	6,504,066
Balance (in shares) at Jun. 30, 2019	66,645,257,694			20,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with cashless exercise of Series A warrants	$ 5,323	(3,112)			2,211
Issuance of common stock in connection with cashless exercise of Series A warrants (in shares)	53,236,547
Issuance of awarded stock for board members	$ 100,000	(100,000)			0
Issuance of awarded stock for board members (in shares)	1,000,000,000
Stock-based compensation expense		147,570			147,570
Net loss			(1,150,303)		(1,150,303)
Balance at Sep. 30, 2019	$ 6,769,849	7,587,828	(29,004,249)	$ 20,150,116	5,503,544
Balance (in shares) at Sep. 30, 2019	67,698,494,241			20,150
Balance at Dec. 31, 2019	$ 6,769,849	7,618,245	(28,636,479)	$ 20,150,116	5,901,731
Balance (in shares) at Dec. 31, 2019	67,698,494,244			20,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with cashless exercise of Series A warrants	$ 3,741,235	(3,741,235)			$ 0
Issuance of common stock in connection with cashless exercise of Series A warrants (in shares)	37,412,353,772				37,412,353,771
Stock-based compensation expense		76,154			$ 76,154
Net loss			(2,810,939)		(2,810,939)
Balance at Sep. 30, 2020	$ 10,511,084	3,953,164	(31,447,418)	$ 20,150,116	3,166,946
Balance (in shares) at Sep. 30, 2020	105,110,848,016			20,150
Balance at Jun. 30, 2020	$ 8,755,829	5,706,544	(30,146,453)	$ 20,150,116	4,466,036
Balance (in shares) at Jun. 30, 2020	87,558,296,598			20,150
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with cashless exercise of Series A warrants	$ 1,755,255	(1,755,255)			0
Issuance of common stock in connection with cashless exercise of Series A warrants (in shares)	17,552,551,418
Stock-based compensation expense		1,875			1,875
Net loss			(1,300,965)		(1,300,965)
Balance at Sep. 30, 2020	$ 10,511,084	$ 3,953,164	$ (31,447,418)	$ 20,150,116	$ 3,166,946
Balance (in shares) at Sep. 30, 2020	105,110,848,016			20,150